Evidence map›Paper›PMID 27042257›Full record

ArticleOxidative medicine and cellular longevity2016

Abnormal Expressions of DNA Glycosylase Genes NEIL1, NEIL2, and NEIL3 Are Associated with Somatic Mutation Loads in Human Cancer.

Kazuya Shinmura, Hisami Kato, Yuichi Kawanishi, Hisaki Igarashi, Masanori Goto, Hong Tao, Yusuke Inoue, Satoki Nakamura, Kiyoshi Misawa, Hiroyuki Mineta and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Research progress on the role of the NEIL family in cancer.Frontiers in cell and developmental biology · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Kazuya ShinmuraDepartment of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Hisami KatoDepartment of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Yuichi KawanishiResearch Equipment Center, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Hisaki IgarashiDepartment of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Masanori GotoDivision of Carcinogenesis and Prevention, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Hong TaoDepartment of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Yusuke InoueDepartment of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Satoki NakamuraDepartment of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Kiyoshi MisawaDepartment of Otolaryngology/Head and Neck Surgery, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Hiroyuki MinetaDepartment of Otolaryngology/Head and Neck Surgery, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Haruhiko SugimuraDepartment of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Hamamatsu University School of Medicine · JPGenesis Research Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effects of abnormalities in the DNA glycosylases NEIL1, NEIL2, and NEIL3 on human cancer have not been fully elucidated. In this paper, we found that the median somatic total mutation loads and the median somatic single nucleotide mutation loads exhibited significant inverse correlations with the median NEIL1 and NEIL2 expression levels and a significant positive correlation with the median NEIL3 expression level using data for 13 cancer types from the Cancer Genome Atlas (TCGA) database. A subset of the cancer types exhibited reduced NEIL1 and NEIL2 expressions and elevated NEIL3 expression, and such abnormal expressions of NEIL1, NEIL2, and NEIL3 were also significantly associated with the mutation loads in cancer. As a mechanism underlying the reduced expression of NEIL1 in cancer, the epigenetic silencing of NEIL1 through promoter hypermethylation was found. Finally, we investigated the reason why an elevated NEIL3 expression level was associated with an increased number of somatic mutations in cancer and found that NEIL3 expression was positively correlated with the expression of APOBEC3B, a potent inducer of mutations, in diverse cancers. These results suggested that the abnormal expressions of NEIL1, NEIL2, and NEIL3 are involved in cancer through their association with the somatic mutation load.

Indexed as

MutationAgedCell Line, TumorDNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesDNA MethylationFemaleGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticGenetic Association StudiesHumansMaleMiddle AgedNeoplasmsN-Glycosyl HydrolasesDNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesNEIL1 protein, humanNEIL2 protein, humanNEIL3 protein, humanN-Glycosyl Hydrolases

Identifiers

PMID27042257
PMCPMC4794593
OpenAlexW2288234973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.